About Rodolphe Barrangou
Rodolphe Barrangou is a co-founder, CSO / part time and director at Ancilia Biosciences.
Form D filings also name Rodolphe Barrangou as a director at Hoofprint Biome.
Rodolphe Barrangou first appears on SEC filings in 2023.
Experience
This experience comes from Rodolphe Barrangou's profile and from SEC filings. For roles taken from filings, the years are when the filings name Rodolphe Barrangou in the role, so the role may have started earlier or lasted longer.
KF
Ki Tua Fund Current
Board of Directors
2023 – Present
Ancilia Biosciences, Inc. Current
Co-founder, CSO / Part Time and director
Co-Founder and CSO (2019 – Present)
2019 – Present · New York, NY
Develops virus-resistant bacterial therapies for human health and other uses.
IN
Inari Current
Scientific Advisory Board
2018 – Present
TJ
The CRISPR Journal Current
Editor In Chief
2017 – Present
II
Intellia Therapeutics, Inc. Current
Co-Founder
2014 – Present
NU
North Carolina State University Current
T. R. Klaenhammer Distinguished Professor
2013 – Present
IS
Invaio Sciences
Scientific Advisory Board
2019 – 2025
LI
Locus Biosciences, Inc.
Co-Founder, CSO and SAB Chairman
2016 – 2018
CB
Caribou Biosciences
Chairman of the BOD
2013 – 2016
PU
Penn State University
Adjunct Professor
2010 – 2016
DU
DuPont
R&D Director
2005 – 2013
Key Colleagues at Startups
The people Rodolphe Barrangou works with at each company, as listed on that company's latest Form D.
Ancilia Biosciences, Inc. · Form D, Apr 6, 2026
Alexandra Sakatos
Co-founder, CEO and director
DP
Dale Pfost
Director
VS
Vera Schroeder
Director
Gurdane Bhutani
Director
Hoofprint Biome, Inc. · Form D, May 27, 2025
ES
Evan Savell
Executive officer
PB
Po Bronson
Director
SC
Scott Collins
Executive officer and director
DM
David Macdonald
Director
KP
Kathryn Polkoff
Chief Executive Officer and director